CompanyGraph
Suzhou MedicalSystem Technology Co., Ltd.
603990 · SSE · China
medicalsystem.com.cnFinancials as of FY2025
What stands out
- Valued far above the size of its business
At a glance
- Depends onMidstream position: 5 outgoing, 6 incoming connections
- ScaleLevered free cash flow is $40.91M, above the global median of $16.24M
- PositionP/E ratio is 378.33×, higher than 95% of its Health Information Services peers (median 44.38×)
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Valued far above the size of its business
Financials view
Market Capitalization
6.79BCNY1.01B · vs all stocks (USD)
Trailing P/E
378.33xvs Health Information Services peers
Revenue (TTM)
299.83MCNY44.59M · vs all stocks (USD)
Profit Margin
6.47%vs Health Information Services peers
Beta
0.4960xvs all stocks
52-Week Change
47.06%vs all stocks
Market Capitalization
6.79BCNY1.01B · vs all stocks (USD)
Enterprise Value
6.87BCNY1.02B · vs all stocks (USD)
Trailing P/E
378.33xvs Health Information Services peers
Forward P/E
20.09xvs Health Information Services peers
Price to Sales (TTM)
23.11xvs Health Information Services peers
Price to Book (MRQ)
8.16xvs Health Information Services peers
Enterprise to Revenue
22.92xvs Health Information Services peers
Gross Margin
62.20%vs Health Information Services peers
Profit Margin
6.47%vs Health Information Services peers
Operating Margin
9.91%vs Health Information Services peers
Return on Assets (TTM)
0.72%vs Health Information Services peers
Return on Equity (TTM)
2.48%vs Health Information Services peers
Revenue (TTM)
299.83MCNY44.59M · vs all stocks (USD)
Revenue per Share (TTM)
0.9260CNYUpdated Aug 21, 2026Quarterly Revenue Growth
-2.60%vs Health Information Services peers
Gross Profit (TTM)
178.48MCNY26.54M · vs all stocks (USD)
EBITDA (TTM)
48.62MCNY7.23M · vs all stocks (USD)
Net Income (TTM)
19.41MCNY2.89M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-83.70%vs Health Information Services peers
Operating Cash Flow (TTM)
75.95MCNY11.29M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
275.12MCNY40.91M · vs all stocks (USD)
5-Year Average Dividend Yield
0.41%vs all stocks
Payout Ratio
0.00%vs Health Information Services peers
Minority Interest (Equity)
10.49MCNYFY2025 · Dec 31, 2025Revenue
301.48MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
119.28MCNYFY2025 · Dec 31, 2025Gross Profit
182.20MCNYFY2025 · Dec 31, 2025Operating Income
22.61MCNY3.36M · vs all stocks (USD)
Pre-tax Income
45.40MCNYFY2025 · Dec 31, 2025Income Tax Expense
3.91MCNYFY2025 · Dec 31, 2025Net Income
41.49MCNYFY2025 · Dec 31, 2025EBIT
58.29MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
83.83MCNYFY2025 · Dec 31, 2025Research & Development
28.60MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
46.57MCNYFY2025 · Dec 31, 2025Other Operating Expenses
4.26MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
8.26MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
12.89MCNYFY2025 · Dec 31, 2025Net Income from Continuing Operations
41.49MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-2.33MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
98.81MCNYFY2025 · Dec 31, 2025Free Cash Flow
31.63MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
277.84MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
41.49MCNYFY2025 · Dec 31, 2025Other Non-cash Items
14.15MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
33.54MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
9.64MCNYFY2025 · Dec 31, 2025Capital Expenditures
-67.19MCNYFY2025 · Dec 31, 2025Net Acquisitions
274.04MCNYFY2025 · Dec 31, 2025Purchase of Investments
-525.20MCNYFY2025 · Dec 31, 2025Sale of Investments
565.97MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
247.62MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
222.19MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-382.70MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-10.22MCNYFY2025 · Dec 31, 2025Other Financing Charges
35.76MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-134.97MCNYFY2025 · Dec 31, 2025Shares Outstanding
306.28MSharesUpdated Aug 21, 2026Float Shares
233.40MSharesUpdated Aug 21, 2026% Held by Insiders
27.68%vs all stocks
% Held by Institutions
0.11%vs all stocks
Total Cash (MRQ)
538.43MCNY80.07M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.78CNYUpdated Aug 21, 2026Total Debt (MRQ)
262.22MCNY39.00M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.3086xvs Health Information Services peers
Current Ratio (MRQ)
2.35xvs Health Information Services peers
Book Value per Share (MRQ)
2.78CNYUpdated Aug 21, 2026Total Assets
1.24BCNY184.78M · vs all stocks (USD)
Total Current Assets
797.30MCNYFY2025 · Dec 31, 2025Total Liabilities
397.15MCNYFY2025 · Dec 31, 2025Total Non-current Assets
445.27MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
54.12MCNYFY2025 · Dec 31, 2025Total Current Liabilities
343.03MCNYFY2025 · Dec 31, 2025Cash
277.62MCNYFY2025 · Dec 31, 2025Cash Equivalents
16.35MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
293.97MCNYFY2025 · Dec 31, 2025Accounts Receivable
175.76MCNYFY2025 · Dec 31, 2025Inventory
31.43MCNYFY2025 · Dec 31, 2025Accounts Payable
43.56MCNYFY2025 · Dec 31, 2025Short-term Debt
220.13MCNYFY2025 · Dec 31, 2025Other Current Liabilities
1.63MCNYFY2025 · Dec 31, 2025Long-term Debt
54.12MCNYFY2025 · Dec 31, 2025Common Stock (Book)
306.28MCNYFY2025 · Dec 31, 2025Retained Earnings
-199.67MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
845.41MCNY125.72M · vs all stocks (USD)
Treasury Stock
61.37MCNYFY2025 · Dec 31, 202552-Week Low
13.74CNYUpdated Aug 21, 202652-Week High
25.03CNYUpdated Aug 21, 202652-Week Change
47.06%vs all stocks
Beta
0.4960xvs all stocks
50-Day MA
20.54CNYUpdated Aug 21, 2026200-Day MA
16.97CNYUpdated Aug 21, 2026Avg 10-Day Volume
32.70MSharesUpdated Aug 21, 2026Avg 30-Day Volume
25.25MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.0600CNYUpdated Aug 21, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
P/E ratio is 378.33×, higher than 95% of its Health Information Services peers (median 44.38×)Significant
P/E ratio: 378.333Industry median: 44.38Industry P95: 218.119Peers compared: 33.00
Structural Tensions
Valued far above the size of its businessSignificant
Price-to-Sales: 23.11Revenue Growth YoY: -0.03
High gross margins eroded by operating costsNotable
Gross Margin: 0.62Profit Margin: 0.06
Financial Health
Altman Z-Score 10.88: safe zoneNotable
Altman Z-Score: 10.88
Supply Chain
Midstream position: 5 outgoing, 6 incoming connectionsNotable
Outgoing: 5.00Incoming: 6.00
High connectivity hub: 11 industry connectionsNotable
Total Connections: 11.00
Scale
Levered free cash flow is $40.91M, above the global median of $16.24MNotable
Levered free cash flow (USD): 40,913,518.726Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Intellect Design Arena Ltd.
Tier 1ProductionRecurring-Revenue Lock-InSenseMakingFlow
Brainaura Medical Technology
Tier 1ProductionRecurring-Revenue Lock-InSenseMakingInterface
Guochuang Software Co. Ltd.
Tier 1ProductionRecurring-Revenue Lock-InSenseMakingInterface
Beijing Egova Co., Ltd.
Tier 1ProductionRecurring-Revenue Lock-InSenseMakingInterface
Inspur International Limited
Tier 1ProductionRecurring-Revenue Lock-InFlowInterface
Asiainfo Technologies Limited
Tier 1ProductionRecurring-Revenue Lock-InFlowSenseMaking
Shenzhen Sunline Tech Co., Ltd.
Tier 1ProductionRecurring-Revenue Lock-InFlowRisk
Jiangsu Tongxingbao Intelligent Co., Ltd.
Tier 1ProductionRecurring-Revenue Lock-InFlowSenseMaking
Beijing E-Hualu Information Technology Co., Ltd.
Tier 1ProductionRecurring-Revenue Lock-InSenseMakingFlow
Fujian Boss Software Development Co., Ltd.
Tier 1ProductionRecurring-Revenue Lock-InSenseMakingFlow